Wenjun Hu1, Lihua Chen 1, Liangjie Lin2, Xu Dai2, Jiazheng Wang 2, and Ailian Liu1
1Department of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian, China, 2Philips Healthcare, Beijing, China
Synopsis
Bone metastasis is an important issue in the management of prostate cancer,
and can drastically alter the treatment strategy. PET/CT has been widely used in the diagnosis of bone
metastasis; however, the high cost and radiation exposure limit its extensive
clinical applications. APT-weighted imaging and IVIM, recent developed function-oriented
MRI sequences, allow for a non-invasive visualization of tissue composition and
microscopic information without the need for contrast agents. Results of this
study indicate the APT value and IVIM parameters
can effectively predict bone metastases in prostate cancer. A combination of
APT and D* mono can further improve the prediction performance.
Introduction
Prostate cancer is the third
most common malignancy after lung and breast malignancies1. Bone
metastases (BM) are very common in prostate cancer. PET/CT is recognized as an
effective method to detect BM, but a whole-body bone investigation will
increase unnecessary radiation burden and diagnostic expenses for a high number
of low risk prostate cancer patients. Therefore, looking for a reliable tool
for predicting the probability of BM and determining the indication for bone
nuclide scans is of great importance. Amide proton
transfer-weighted (APTw) imaging
generates image contrast using endogenous mobile proteins and peptides in
tissue2. Intravoxel incoherent motion imaging (IVIM) can reflect
both diffusion and micro-perfusion information of lesions3. The
purpose of this study is to explore the value of APT and IVIM parameters in predicting
BM of prostate cancer.Method
36 patients with
pathologically confirmed prostate cancer were involved in this study. According
to the state of the skeleton diagnosed by PET-CT, the patients were divided
into two groups: group A (13 patients) with BM and group B (23patients) without
BM. They underwent preoperative pelvic 3.0T MR scans (Ingenia CX, Philips Healthcare, Best, the Netherlands) with a
32-channel abdominal array coil. The scanned MR sequences included APT, IVIM, DWI, etc. Detailed parameters were
listed in Table 1. With reference to T2WI and DWI images, two radiologists used
a double-blind method to place a circular-like ROI on the largest layer of the
lesion to measure APT value and parameters of IVIM. An unpaired t-test was used
to analyze the differences of APT value and parameters of IVIM between the two
groups, and the ROC curves were used to evaluate the diagnostic efficacy of
these parameters in predicting BM of prostate cancer.Results
The consistency of the data
obtained by the two observers was good (ICC value > 0. 75). The
APT and D*-mono values of the PCa group
A were significantly higher than those of group B (P<0.05). The standard
ADC, fmono, and fbi values of group A were significantly
lower than those of group B (P<0.05). No significant
difference of D-mono, D-bi, D*-bi was observed between the two
groups (P>0.05). The area under the ROC curve (AUC) of APT, standard ADC, D*-mono,
fmono, fbi on predicting BM of prostate cancer were 0.774,
0.719, 0.694, 0.806 and 0.799, respectively. With combination of APT and fmono,
the AUC of ROC analysis was improved to be 0.866.Discussion and Conclusion
The significant
difference in APT value and IVIM parameters between the two groups may be due
to the more production of mobile protein, higher cell density and greater capillary
blood flow in PCa with BM than
in non-metastases PCa. A combination of APT and IVIM parameters can
greatly improve the differential diagnosis efficiency. In summary,
APT and IVIM has great potential for clinical applications of individualized
prediction of BM in PCa.Acknowledgements
NoReferences
1.
Zhou J, Gou Z, Wu R, Yuan Y, Yu G, Zhao Y.
Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone
scintigraphy in the diagnosis of bone metastases in patients with prostate
cancer: a systematic review and meta-analysis. Skeletal Radiol.
2019;48(12):1915-1924
2.
Ma B, Blakeley JO, Hong X, et al.Applying amide
proton transfer-weighted MRI to distinguish pseudoprogression from true progression
in malignant gliomas. J Magn Reson Imaging,2016, 44(2):456-462
3.
Pesapane F, Patella F, Fumarola EM, et al. Intravoxel Incoherent Motion
(IVIM) Diffusion Weighted Imaging (DWI) in the Periferic Prostate Cancer
Detection and Stratification. Med Oncol. 2017;34(3):35.